Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

The ocular surface

Showing results (261-270 of 1,098) with videos related to

Pageof 110
Sort By:
The Ocular Surface|October 8, 2019
Evaluation of use of essential fatty acids in topical ophthalmic preparations for dry eyePoonam Mudgil
The Ocular Surface|January 15, 2021
Low-dose naltrexone is effective and well-tolerated for modulating symptoms in patients with neuropathic corneal painGabriela Dieckmann, M Cuneyt Ozmen, Stephanie M Cox, et al.
The Ocular Surface|December 10, 2021
The link between Keratoconus and posterior segment parameters: An updated, comprehensive reviewHassan Hashemi, Mohsen Heirani, Renato Ambrósio, et al.
The Ocular Surface|December 13, 2021
Biomarkers of in vivo limbal stem cell functionQihua Le, Tulika Chauhan, Daniel Cordova, et al.
The Ocular Surface|April 18, 2008
The dendritic cell in allergic conjunctivitisBita Manzouri, Tom Flynn, Masaharu Ohbayashi, et al.
The Ocular Surface|December 30, 2021
The Link module of human TSG-6 (Link_TSG6) promotes wound healing, suppresses inflammation and improves glandular function in mouse models of Dry Eye DiseaseJoo Youn Oh, Jin Suk Ryu, Hyeon Ji Kim, et al.
The Ocular Surface|April 10, 2012
Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin)William Stevenson, Sheng-Fu Cheng, Mohammad H Dastjerdi, et al.
The Ocular Surface|April 10, 2012
Report of the TFOS/ARVO Symposium on global treatments for dry eye disease: an unmet needDavid A Sullivan, Katherine M Hammitt, Debra A Schaumberg, et al.
The Ocular Surface|July 28, 2011
Benzalkonium chloride in glaucoma medicationsRobert Noecker, Kimberly V Miller
The Ocular Surface|May 7, 2011
A solute gradient in the tear meniscus. II. Implications for lid margin disease, including meibomian gland dysfunctionAnthony J Bron, Norihiko Yokoi, Eamonn A Gaffney, et al.
Pageof 110

Showing results (261-270 of 1,098) with videos related to

Sort By:
Pageof 110
The Ocular Surface|October 8, 2019
Evaluation of use of essential fatty acids in topical ophthalmic preparations for dry eyePoonam Mudgil
The Ocular Surface|January 15, 2021
Low-dose naltrexone is effective and well-tolerated for modulating symptoms in patients with neuropathic corneal painGabriela Dieckmann, M Cuneyt Ozmen, Stephanie M Cox, et al.
The Ocular Surface|December 10, 2021
The link between Keratoconus and posterior segment parameters: An updated, comprehensive reviewHassan Hashemi, Mohsen Heirani, Renato Ambrósio, et al.
The Ocular Surface|December 13, 2021
Biomarkers of in vivo limbal stem cell functionQihua Le, Tulika Chauhan, Daniel Cordova, et al.
The Ocular Surface|April 18, 2008
The dendritic cell in allergic conjunctivitisBita Manzouri, Tom Flynn, Masaharu Ohbayashi, et al.
The Ocular Surface|December 30, 2021
The Link module of human TSG-6 (Link_TSG6) promotes wound healing, suppresses inflammation and improves glandular function in mouse models of Dry Eye DiseaseJoo Youn Oh, Jin Suk Ryu, Hyeon Ji Kim, et al.
The Ocular Surface|April 10, 2012
Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin)William Stevenson, Sheng-Fu Cheng, Mohammad H Dastjerdi, et al.
The Ocular Surface|April 10, 2012
Report of the TFOS/ARVO Symposium on global treatments for dry eye disease: an unmet needDavid A Sullivan, Katherine M Hammitt, Debra A Schaumberg, et al.
The Ocular Surface|July 28, 2011
Benzalkonium chloride in glaucoma medicationsRobert Noecker, Kimberly V Miller
The Ocular Surface|May 7, 2011
A solute gradient in the tear meniscus. II. Implications for lid margin disease, including meibomian gland dysfunctionAnthony J Bron, Norihiko Yokoi, Eamonn A Gaffney, et al.
Pageof 110